Skip to main content
. 2024 Mar 18;13:e49849. doi: 10.2196/49849

Table 1.

World Health Organization Trial registration data set.

Data category Information
Primary registry and trial identifying number ANZCTR, ACTRN12620000223932
Date of registration in primary registry February 24, 2020
Secondary identifying numbers UTN: U1111-1247-8144
Source of monetary or material support Royal Melbourne Hospital, NorthWestern Mental Health
Primary sponsor Royal Melbourne Hospital, NorthWestern Mental Health
Secondary sponsor La Trobe University
Contact for public enquiries Dr Eric Morris
Contact for scientific enquiries Dr Marilyn Cugnetto
Public title Acceptance and Commitment Therapy (ACT) Group Program for Recovery from Psychosis: A Multi-Agency Evaluation
Scientific title A Multi-agency Evaluation of the Routine Practice of an Acceptance and Commitment Therapy Group for Recovery from Psychosis
Countries of recruitment Australia
Heath conditions or problems studied Psychosis, Mental Health, Schizophrenia
Interventions Treatment: “Recovery ACT for Psychosis” Group Program; comparator or control: single group, waitlist control period
Key inclusion and exclusion criteria

Inclusion criteria Inclusion criteria: Out-patients aged between 18 and 65 years; have a primary file diagnosis of either a schizophrenia spectrum or other psychotic disorder, a mood disorder with psychotic features, or a substance-induced psychotic disorder; are currently receiving outpatient mental health care at one of the study centers; are self-referred or referred by clinical staff to a Recovery ACT group being conducted by a participating center.

Exclusion criteria Exclusion criteria: lack of capacity to consent to this evaluation; lack of proficiency in speaking and comprehending English; file diagnosis of an intellectual disability (an intellectual development disorder) or borderline personality disorder.
Study type Interventional
Allocation
  • Nonrandomized trial

  • Intervention assignment: single-group

  • Masking: open (masking not used)

Primary purpose Treatment
Phase N/Aa
Date of first enrollment September 13, 2019
Target sample size 160
Recruitment status Recruiting
Primary outcomes Personal recovery
Key secondary outcomes Well-being

aN/A: not applicable.